ArticleMolecular cancer therapeutics2023

Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma.

Ilgen Mender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.